Colony Group LLC Bluebird Bio, Inc. Transaction History
Colony Group LLC
- $6.66 Billion
- Q3 2023
A detailed history of Colony Group LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Colony Group LLC holds 41,942 shares of BLUE stock, worth $208,451. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,942
Previous 39,319
6.67%
Holding current value
$208,451
Previous $129,000
0.78%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BLUE
# of Institutions
14Shares Held
20.2MCall Options Held
0Put Options Held
2K-
Black Rock Inc. New York, NY15.4MShares$76.7 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$23.2 Million0.02% of portfolio
-
Connacht Asset Management LP New York, NY31.6KShares$157,2200.59% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL28.7KShares$142,6880.0% of portfolio
-
Cutler Group LP800Shares$3,9760.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $383M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...